The Relationship Between GBS Screening in Pregnant Women Insured in Maccabi Healthcare Services (MHS) and Early-onset Neonatal Disease in Israel

Assuta Hospital Systems54,759 enrolled

Overview

Determination of GBS colonization rates in Pregnant Women insured with Maccabi Health Services, Doctors' Compliance Rates for Referral for Testing, test execution rates, and Early-onset GBS Disease (EOGBSD) Rates in Israel. Determine the relationship between conducting a GBS test in pregnant women and EOGBSD in Israel.

There have been few studies in recent years, which has prompted us to undertake this study. Our aim was to examine the current colonization rates and attack rates in the Israeli population. Our secondary aim was to evaluate the need to readjust recommendations towards universal screening.

Study Type

OBSERVATIONAL

Enrollment

54,759

Conditions

Streptococcal Infection Group B as Cause of Diseases Classified Elsewhere (Diagnosis)

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * All women with term pregnancies from 2015 to 2016 (until 20/9/16) insured by Maccabi Healthcare Services (MHS) Exclusion Criteria: * repeat pregnancies occurring in the same woman during the time period * multiple pregnancies * gestational age greater than 42 weeks due to probability of data inaccuracy * women with missing information

Outcomes

Primary Outcomes

Attack rate of early-onset GBS disease (EOGBSD)

Attack rate of (EOGBSD)

Time frame: 2015-2016

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.